Comment
doi: 10.1038/ncponc0879.
Epub 2007 Jul 3.
Angiogenesis inhibition: the next frontier in multimodal therapy for glioblastoma multiforme
Affiliations
- PMID: 17609654
- DOI: 10.1038/ncponc0879
Item in Clipboard
Comment
Angiogenesis inhibition: the next frontier in multimodal therapy for glioblastoma multiforme
Nat Clin Pract Oncol.
2007 Aug.
No abstract available
Comment on
-
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.Cancer Cell. 2007 Jan;11(1):83-95. doi: 10.1016/j.ccr.2006.11.021. Cancer Cell. 2007. PMID: 17222792 Free PMC article. Clinical Trial.
Similar articles
-
Congenital glioblastoma multiforme: case report and review of the literature.Pediatr Neurosurg. 2008;44(4):304-12. doi: 10.1159/000134922. Epub 2008 May 27. Pediatr Neurosurg. 2008. PMID: 18504417 Review.
-
Glioblastoma multiforme following cranial irradiation and chemotherapy for acute lymphocytic leukaemia. Report of 3 cases.Pediatr Neurosurg. 2007;43(5):369-74. doi: 10.1159/000106385. Pediatr Neurosurg. 2007. PMID: 17786001
-
Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.Clin Cancer Res. 2007 Dec 1;13(23):7155-65. doi: 10.1158/1078-0432.CCR-07-1306. Clin Cancer Res. 2007. PMID: 18056196
-
Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.Clin Cancer Res. 2009 Oct 1;15(19):6258-66. doi: 10.1158/1078-0432.CCR-08-1867. Epub 2009 Sep 29. Clin Cancer Res. 2009. PMID: 19789313 Clinical Trial.
-
Epigenetic mechanisms in glioblastoma multiforme.Semin Cancer Biol. 2009 Jun;19(3):188-97. doi: 10.1016/j.semcancer.2009.02.005. Epub 2009 Feb 20. Semin Cancer Biol. 2009. PMID: 19429483 Review.
Publication types
LinkOut - more resources
Full Text Sources